Gene polymorphisms in prodynorphin (PDYN) are associated with episodic memory in the elderly
暂无分享,去创建一个
Michael Wagner | Martin Dichgans | Birgitt Wiese | Frank Jessen | Angela Fuchs | Wolfgang Maier | Hanna Kaduszkiewicz | Jochen Werle | Steffi G. Riedel-Heller | F. Jessen | W. Maier | M. Dichgans | B. Wiese | H. Kölsch | E. Mösch | M. Wagner | M. Pentzek | S. Riedel-Heller | S. Weyerer | H. Kaduszkiewicz | H. Bickel | M. Angermeyer | A. Bilkei-Gorzo | J. Werle | M. Toliat | A. Fuchs | Horst Bickel | Matthias C. Angermeyer | Heike Kölsch | Edelgard Mösch | M. Daerr | Siegfried Weyerer | Michael Pentzek | Mohammad Reza Toliat | Andras Bilkei-Gorzó | Hendrik den Bussche | Moritz Daerr | Hendrik den Bussche | A. Bilkei‐Gorzo | Moritz Daerr
[1] Marcus Meinzer,et al. Neural Signatures of Semantic and Phonemic Fluency in Young and Old Adults , 2009, Journal of Cognitive Neuroscience.
[2] J. Ott,et al. A Functional Haplotype Implicated in Vulnerability to Develop Cocaine Dependence is Associated with Reduced PDYN Expression in Human Brain , 2009, Neuropsychopharmacology.
[3] W. Maier,et al. The His452Tyr variant of the gene encoding the 5-HT2A receptor is specifically associated with consolidation of episodic memory in humans. , 2008, The international journal of neuropsychopharmacology.
[4] P Rabbitt,et al. Brain‐derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly , 2008, Genes, brain, and behavior.
[5] V. Haroutunian,et al. Dysregulation of dynorphins in Alzheimer disease , 2007, Neurobiology of Aging.
[6] A. Ardila,et al. Normal aging increases cognitive heterogeneity: analysis of dispersion in WAIS-III scores across age. , 2007, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.
[7] F. Jessen,et al. Mild Cognitive Impairment in General Practice: Age-Specific Prevalence and Correlate Results from the German Study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe) , 2007, Dementia and Geriatric Cognitive Disorders.
[8] F. Jessen,et al. Patterns of subjective memory impairment in the elderly: association with memory performance , 2007, Psychological Medicine.
[9] Edgar Erdfelder,et al. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences , 2007, Behavior research methods.
[10] L. Bierut,et al. Association of the κ-opioid system with alcohol dependence , 2006, Molecular Psychiatry.
[11] Lars-Göran Nilsson,et al. The influence of APOE status on episodic and semantic memory: data from a population-based study. , 2006, Neuropsychology.
[12] Jason J. Corneveaux,et al. Common Kibra Alleles Are Associated with Human Memory Performance , 2006, Science.
[13] L. Terenius,et al. Big Dynorphin, a Prodynorphin-Derived Peptide Produces NMDA Receptor-Mediated Effects on Memory, Anxiolytic-Like and Locomotor Behavior in Mice , 2006, Neuropsychopharmacology.
[14] D. Oslin,et al. A functional prodynorphin promoter polymorphism and opioid dependence , 2005, Psychiatric genetics.
[15] M F Weiner,et al. A total score for the CERAD neuropsychological battery , 2005, Neurology.
[16] T. Foster,et al. Prodynorphin knockout mice demonstrate diminished age-associated impairment in spatial water maze performance , 2005, Behavioural Brain Research.
[17] A. Levine,et al. Age-related changes in brain proDynorphin gene expression in the rat , 2004, Neurobiology of Aging.
[18] Michael Knapp,et al. A powerful strategy to account for multiple testing in the context of haplotype analysis. , 2004, American journal of human genetics.
[19] R. Mohs,et al. Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.
[20] D. Schaid,et al. Score tests for association between traits and haplotypes when linkage phase is ambiguous. , 2002, American journal of human genetics.
[21] E Rauch,et al. An Allelic Variation in the Human Prodynorphin Gene Promoter Alters Stimulus‐Induced Expression , 2000, Journal of neurochemistry.
[22] R. Shafiq-Antonacci,et al. Norms and the Effects of Demographic Variables on a Neuropsychological Battery for Use in Healthy Ageing Australian Populations , 1999, The Australian and New Zealand journal of psychiatry.
[23] B Johansson,et al. Substantial genetic influence on cognitive abilities in twins 80 or more years old. , 1997, Science.
[24] N. Butters,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery , 1994, Neurology.
[25] R. Nicoll,et al. The opioid peptide dynorphin mediates heterosynaptic depression of hippocampal mossy fibre synapses and modulates long-term potentiation , 1993, Nature.
[26] T. Kameyama,et al. Dynorphin A-(1-13) potently prevents memory dysfunctions induced by transient cerebral ischemia in mice. , 1993, European journal of pharmacology.
[27] D. T. Vernier,et al. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. , 1990, Journal of lipid research.
[28] M. Gallagher,et al. Elevated dynorphin in the hippocampal formation of aged rats: relation to cognitive impairment on a spatial learning task. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[29] E. Hall,et al. Pathobiology of dynorphins in trauma and disease. , 2005, Frontiers in bioscience : a journal and virtual library.